Miles Congreve
Corporate Officer/Principal chez Heptares Therapeutics Ltd.
Provenance du réseau au premier degré de Miles Congreve
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Miles Congreve via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chief Executive Officer | |
Tal Medical, Inc.
 Tal Medical, Inc. Medical SpecialtiesHealth Technology Tal Medical, Inc. operates as a clinical stage medical device company. It develops novel, non contact, neuromodulatory devices for the treatment of psychiatric and neurological disorders. The firm focuses on the development of LFMS for the treatment of major depressive disorder and bipolar depression. The company was founded by Daphne Zohar, Steven Marc Paul, Andrew Miller, Eric Elenko and Nessan Bermingham in 2010 and is headquartered in Boston, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| EVOTEC SE | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| University of Glasgow | College/University | Doctorate Degree | |
Cambridge Drug Discovery Holdings Ltd.
 Cambridge Drug Discovery Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Charles River Laboratories International, Inc., Cambridge Drug Discovery Holdings Ltd. is a company that researches potential new drugs for the treatment of cancer. The company is based in Cambridge, UK. Cambridge Drug Discovery Holdings was acquired by Charles River Discovery Research Services UK Ltd., part of Charles River Laboratories International, Inc. from November 14, 2005 on June 11, 2001 for $38 million. The British company was founded by Barry Kenny, Jonathan Mark Treherne. | Miscellaneous Commercial Services | Founder | |
| University of Leeds | College/University | Doctorate Degree | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Apax Partners Holdings Ltd.
 Apax Partners Holdings Ltd. Financial ConglomeratesFinance Apax Partners Holdings Ltd. provides investment services. The firm focuses in the area of media, retail, health care, financial, and telecommunication sectors. The company was founded on February 6, 1991 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Corporate Officer/Principal | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ABLYNX | Biotechnology | Director/Board Member Director/Board Member | |
| The University of Nottingham | College/University | Doctorate Degree | |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Director/Board Member | |
| NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Executive Officer | |
Takeda Cambridge Ltd.
 Takeda Cambridge Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Cambridge Ltd. is a company that develops and manufactures pharmaceutical products. The company is based in Cambridge, UK and was founded in 1998. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Private Equity Analyst | |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Investment Managers | Private Equity Investor | |
Pfizer Europe International Ltd.
 Pfizer Europe International Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Europe International Ltd. is an Irish company. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Parke-Davis Pharmaceutical Research, Inc. | Director/Board Member | ||
| University of Lucknow | College/University | Doctorate Degree | |
Biofocus, Inc.
 Biofocus, Inc. Pharmaceuticals: MajorHealth Technology Biofocus, Inc. operates as a clinical biotechnology company. The company is headquartered in the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SmithKline Beecham Ltd.
 SmithKline Beecham Ltd. Pharmaceuticals: MajorHealth Technology Smithkline Beecham Ltd. manufacture of basic pharmaceutical products. It also provides mineral water, bottled water, and soft drinks. The company was founded on January 24, 1989 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member | |
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Baines Peter Consulting | Director/Board Member | ||
| University of Michigan Medical School | College/University | Corporate Officer/Principal | |
| Verity BioConsulting LLC | Chief Executive Officer | ||
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member | |
| PURETECH HEALTH PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Metrion Biosciences Ltd.
 Metrion Biosciences Ltd. BiotechnologyHealth Technology Metrion Biosciences Ltd. is a contract research organization that specializes in providing drug discovery services to pharmaceutical and bioscience customers. Metrion Biosciences is based in Great Abington, UK and was founded in 2015. The British company offers a range of high-quality ion channel assays on a fee-for-service or collaboration basis, including an industry-leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimization. Andrew Southan has been the CEO of the company since 2016. | Biotechnology | Director/Board Member | |
Perception Neuroscience, Inc.
 Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Biotechnology | Director/Board Member | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member | |
Myricx Pharma Ltd.
 Myricx Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Myricx Pharma Ltd. engages in the development of novel proprietary inhibitors of human N-myristoyltransferases. The company was founded by Ed Tate, Roberto Solari, and Andrew Bell in 2019 and is headquartered in Stevenage, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Apterna Ltd. | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Royaume-Uni | 21 |
| Etats-Unis | 20 |
| Irlande | 3 |
| Inde | 3 |
| Australie | 3 |
Sectorielle
| Health Technology | 34 |
| Consumer Services | 6 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 94 |
| Corporate Officer/Principal | 40 |
| Chairman | 26 |
| Independent Dir/Board Member | 21 |
| Chief Tech/Sci/R&D Officer | 15 |
Relations les plus connectées
| Insiders | |
|---|---|
| Declan Doogan | 28 |
| John Bradshaw | 27 |
| John Berriman | 24 |
| Atul Pande | 20 |
| Roger Perlmutter | 19 |
| Peter Bains | 19 |
| Daniel S. Grau | 13 |
| Roberto Solari | 10 |
| Malcolm Weir | 9 |
| Barry Kenny | 8 |
| David McGibney | 5 |
| Tim Tasker | 4 |
| Chris Cargill | 4 |
| Ed Hulme | 1 |
| Beverly Lybrand | 1 |
- Bourse
- Insiders
- Miles Congreve
- Connexions Sociétés
